The COVID-19 Impact on the Trends in Yellow Fever and Lassa Fever Infections in Nigeria
Lassa fever (LF) and yellow fever (YF) belong to a group of viral hemorrhagic fevers (VHFs). These viruses have common features and damages the organs and blood vessels; they also impair the body’s homeostasis. Some VHFs cause mild disease, while some cause severe disease and death such as in the ca...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2022-11-01
|
| Series: | Infectious Disease Reports |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2036-7449/14/6/91 |
| _version_ | 1827638500150738944 |
|---|---|
| author | Nnennaya U. Opara Ugochinyere I. Nwagbara Khumbulani W. Hlongwana |
| author_facet | Nnennaya U. Opara Ugochinyere I. Nwagbara Khumbulani W. Hlongwana |
| author_sort | Nnennaya U. Opara |
| collection | DOAJ |
| description | Lassa fever (LF) and yellow fever (YF) belong to a group of viral hemorrhagic fevers (VHFs). These viruses have common features and damages the organs and blood vessels; they also impair the body’s homeostasis. Some VHFs cause mild disease, while some cause severe disease and death such as in the case of Ebola or Marburg. LF virus and YF virus are two of the most recent emerging viruses in Africa, resulting in severe hemorrhagic fever in humans. Lassa fever virus is continuously on the rise both in Nigeria and neighboring countries in West Africa, with an estimate of over 500,000 cases of LF, and 5000 deaths, annually. YF virus is endemic in temperate climate regions of Africa, Central America (Guatemala, Honduras, Nicaragua, El Salvador), and South America (such as Brazil, Argentina, Peru, and Chile) with an annual estimated cases of 200,000 and 30,000 deaths globally. This review examines the impact of the COVID-19 pandemic on the trend in epidemiology of these two VHFs to delineate responses that are associated with protective or pathogenic outcomes. |
| first_indexed | 2024-03-09T16:21:10Z |
| format | Article |
| id | doaj.art-e8469d45cd9748528b5606be1a576eda |
| institution | Directory Open Access Journal |
| issn | 2036-7449 |
| language | English |
| last_indexed | 2024-03-09T16:21:10Z |
| publishDate | 2022-11-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Infectious Disease Reports |
| spelling | doaj.art-e8469d45cd9748528b5606be1a576eda2023-11-24T15:18:12ZengMDPI AGInfectious Disease Reports2036-74492022-11-0114693294110.3390/idr14060091The COVID-19 Impact on the Trends in Yellow Fever and Lassa Fever Infections in NigeriaNnennaya U. Opara0Ugochinyere I. Nwagbara1Khumbulani W. Hlongwana2Institute for Academic Medicine, Department of Emergency Medicine, Charleston Area Medical Center, Charleston, WV 25304, USADepartment of Public Health Medicine, College of Health Sciences, University of KwaZulu-Natal, Howard Campus, Durban 4041, South AfricaCancer and Infectious Disease Epidemiology Research Unit (CIDERU), College of Health Sciences, University of KwaZulu-Natal, Durban 4041, South AfricaLassa fever (LF) and yellow fever (YF) belong to a group of viral hemorrhagic fevers (VHFs). These viruses have common features and damages the organs and blood vessels; they also impair the body’s homeostasis. Some VHFs cause mild disease, while some cause severe disease and death such as in the case of Ebola or Marburg. LF virus and YF virus are two of the most recent emerging viruses in Africa, resulting in severe hemorrhagic fever in humans. Lassa fever virus is continuously on the rise both in Nigeria and neighboring countries in West Africa, with an estimate of over 500,000 cases of LF, and 5000 deaths, annually. YF virus is endemic in temperate climate regions of Africa, Central America (Guatemala, Honduras, Nicaragua, El Salvador), and South America (such as Brazil, Argentina, Peru, and Chile) with an annual estimated cases of 200,000 and 30,000 deaths globally. This review examines the impact of the COVID-19 pandemic on the trend in epidemiology of these two VHFs to delineate responses that are associated with protective or pathogenic outcomes.https://www.mdpi.com/2036-7449/14/6/91Lassa feveryellow feverCOVID-19VHFs |
| spellingShingle | Nnennaya U. Opara Ugochinyere I. Nwagbara Khumbulani W. Hlongwana The COVID-19 Impact on the Trends in Yellow Fever and Lassa Fever Infections in Nigeria Infectious Disease Reports Lassa fever yellow fever COVID-19 VHFs |
| title | The COVID-19 Impact on the Trends in Yellow Fever and Lassa Fever Infections in Nigeria |
| title_full | The COVID-19 Impact on the Trends in Yellow Fever and Lassa Fever Infections in Nigeria |
| title_fullStr | The COVID-19 Impact on the Trends in Yellow Fever and Lassa Fever Infections in Nigeria |
| title_full_unstemmed | The COVID-19 Impact on the Trends in Yellow Fever and Lassa Fever Infections in Nigeria |
| title_short | The COVID-19 Impact on the Trends in Yellow Fever and Lassa Fever Infections in Nigeria |
| title_sort | covid 19 impact on the trends in yellow fever and lassa fever infections in nigeria |
| topic | Lassa fever yellow fever COVID-19 VHFs |
| url | https://www.mdpi.com/2036-7449/14/6/91 |
| work_keys_str_mv | AT nnennayauopara thecovid19impactonthetrendsinyellowfeverandlassafeverinfectionsinnigeria AT ugochinyereinwagbara thecovid19impactonthetrendsinyellowfeverandlassafeverinfectionsinnigeria AT khumbulaniwhlongwana thecovid19impactonthetrendsinyellowfeverandlassafeverinfectionsinnigeria AT nnennayauopara covid19impactonthetrendsinyellowfeverandlassafeverinfectionsinnigeria AT ugochinyereinwagbara covid19impactonthetrendsinyellowfeverandlassafeverinfectionsinnigeria AT khumbulaniwhlongwana covid19impactonthetrendsinyellowfeverandlassafeverinfectionsinnigeria |